Doxycycline-induced staining of permanent adult dentition

Australian Dental Journal

Volumn 50, Issue 4, 2005, Pages 273-275

  Ayaslioglu, E ^a   Erkek, E ^a,c   Oba, A A ^a   Cebecioglu E ^b  

^a KIRIKKALE UNIVERSITY   (Turkey)

^b CE SA Medical Center   (Turkey)

^c NONE   (Turkey)

Author keywords

Doxycycline; Side effects; Teeth discolouration; Teeth staining; Tetracycline

Indexed keywords

ANTIINFECTIVE AGENT; DOXYCYCLINE; RIFAMPICIN; STREPTOMYCIN;

ADOLESCENT; ADULT; ARTICLE; BRUCELLOSIS; CASE REPORT; CHEMICALLY INDUCED DISORDER; CHILD; FEMALE; FOLLOW UP; HUMAN; MALE; METHODOLOGY; SUNLIGHT; TOOTH BRUSHING; TOOTH DISCOLORATION;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BRUCELLOSIS; CHILD; DOXYCYCLINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; RIFAMPIN; STREPTOMYCIN; SUNLIGHT; TOOTH DISCOLORATION; TOOTHBRUSHING;

EID: 30444440759     PISSN: 00450421     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1834-7819.2005.tb00373.x     Document Type: Article

References (21)

1. Standiford HC. Tetracyclines and chloramphenicol. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 5th edn. New York: Churchill Livingstone, 2000:336, 348.
2. Ariza J, Gudiol F, Pallares R, Viladrich PF, Rufi G, Corredoira J, Miravitlles MR. Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. A randomized, double-blind study. Ann Intern Med 1992;117:25-30.
3. Morrow GL, Abbott RL. Minocycline-induced scleral, dental, and dermal pigmentation. Am J Ophtalmol 1998;125:396-397.
4. Solera J, Martinez-Alfaro E, Espinosa A. Recognition and optimum treatment of brucellosis. Drugs 1997;53:245-256.
5. Shetty AK. Tetracyclines in pediatrics revisited. Clin Pediatr 2002;41:203-209.
6. Committee on Infectious Diseases and Immunization of the Canadian Pediatric Society (CPS). Tetracycline use in children update. URL: 'http://www.cpc.ca/english/statements/ID/id9402.htm'. Accessed September 2004.
7. Layton AM, Cunliffe WJ. Phototoxic eruptions due to doxycycline - a dose-related phenomenon. Clin Exp Dermatol 1993;18:425-427.
8. Bonnetblanc JM. Doxycycline. Ann Dermatol Venereol 2002;129:874-882.
9. Bjellerup M, Ljunggren B. Differences in phototoxic potency should be considered when tetracyclines are prescribed during summer-time. A study on doxycycline and lymecycline in human volunteers, using an objective method for recording erythema. Br J Dermatol 1994;130:356-360.
10. Bryant SG, Fisher S, Kluge RM. Increased frequency of doxycycline side effects. Pharmacotherapy 1987;7:125-129.
11. de Wit ME, Stricker BH, Porsius AJ. Discoloration of teeth by drugs. Ned Tijdschr Tandheelkd 1996;103:3-5.
12. Ayaslioglu E, Erkek E, Beygo B, Cebecioǧlu E. Cutaneous complications of doxcycyline therapy. Infect Med 2004;21:24.
13. Patel K, Cheshire D, Vance A. Oral and systemic effects of prolonged minocycline therapy. Br Dental J 1998;185:560-562.
14. Chan-Tompkins NH. Toxic effects and drug interactions of antimycobacterial therapy. Clin Dermatol 1995;13:223-233.
15. Siller GM, Tod MA, Savage NW. Minocycline-induced oral pigmentation. J Am Acad Dermatol 1994;30:350-354.
16. Lochary ME, Lockhart PB, Williams WT Jr. Doxycycline and staining of permanent teeth. Pediatr Infect Dis J 1998;17:429-431.
17. Kashyap AS, Sharma HS. Discolouration of permanent teeth and enamel hypoplasia due to tetracycline. Postgrad Med J 1999;75:772.
18. Good ML, Hussey DL. Minocycline: stain devil? Br J Dermatol 2003;149:237-239.
19. Rosen T, Hoffmann TJ. Minocycline-induced discoloration of the permanent teeth. J Am Acad Dermatol 1989;21:569.
20. Benavides S, Nahata MC. Anthrax: safe treatment for children. Ann Pharmacother 2002;36:334-337.
21. Ayangco L, Sheridan PJ. Minocycline-induced staining of torus palatinus and alveolar bone. J Periodontol 2003;74:669-671.